Ocera Therapeutics, Inc.
Ocera Therapeutics, Inc. (Form: 4, Received: 02/10/2017 17:22:02)
FORM 4
[ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

THOMAS MCNERNEY & PARTNERS LP
2. Issuer Name and Ticker or Trading Symbol

Ocera Therapeutics, Inc. [ OCRX ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

C/O THOMAS, MCNERNEY & PARTNERS, L.P., 12527 CENTRAL AVENUE NE #297
3. Date of Earliest Transaction (MM/DD/YYYY)

1/30/2017
(Street)

MINNEAPOLIS, MN 55434
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
THOMAS MCNERNEY & PARTNERS LP
C/O THOMAS, MCNERNEY & PARTNERS, L.P.
12527 CENTRAL AVENUE NE #297
MINNEAPOLIS, MN 55434

X

TMP ASSOCIATES LP
C/O THOMAS, MCNERNEY & PARTNERS, L.P.
12527 CENTRAL AVENUE NE #297
MINNEAPOLIS, MN 55434

X

TMP Nominee, LLC
C/O THOMAS, MCNERNEY & PARTNERS, L.P.
12527 CENTRAL AVENUE NE #297
MINNEAPOLIS, MN 55434

X

Thomas, McNerney & Partners, LLC
C/O THOMAS, MCNERNEY & PARTNERS, L.P.
12527 CENTRAL AVENUE NE #297
MINNEAPOLIS, MN 55434

X

Thomas, McNerney & Partners II L.P.
C/O THOMAS, MCNERNEY & PARTNERS, L.P.
12527 CENTRAL AVENUE NE #297
MINNEAPOLIS, MN 55434

X

TMP Associates II LP
C/O THOMAS, MCNERNEY & PARTNERS, L.P.
12527 CENTRAL AVENUE NE #297
MINNEAPOLIS, MN 55434

X

TMP Nominee II, LLC
C/O THOMAS, MCNERNEY & PARTNERS, L.P.
12527 CENTRAL AVENUE NE #297
MINNEAPOLIS, MN 55434

X

Thomas, McNerney & Partners II, LLC
C/O THOMAS, MCNERNEY & PARTNERS, L.P.
12527 CENTRAL AVENUE NE #297
MINNEAPOLIS, MN 55434

X

THOMAS JAMES E
C/O THOMAS, MCNERNEY & PARTNERS, L.P.
12527 CENTRAL AVENUE NE #297
MINNEAPOLIS, MN 55434

X


Signatures
/s/ James E. Thomas, Manager of Thomas, McNerney & Partners, L.P 2/10/2017
** Signature of Reporting Person Date

/s/ James E. Thomas, Manager of TMP Nominee, LLC 2/10/2017
** Signature of Reporting Person Date

/s/ James E. Thomas, Manager of TMP Associates, L.P. 2/10/2017
** Signature of Reporting Person Date

/s/ James E. Thomas, Manager of Thomas, McNerney & Partners, LLC 2/10/2017
** Signature of Reporting Person Date

/s/ James E. Thomas, Manager of Thomas, McNerney & Partners II, L.P 2/10/2017
** Signature of Reporting Person Date

/s/ James E. Thomas, Manager of TMP Nominee II, LLC 2/10/2017
** Signature of Reporting Person Date

/s/ James E. Thomas, Manager of TMP Associates II, L.P. 2/10/2017
** Signature of Reporting Person Date

/s/ James E. Thomas, Manager of Thomas, McNerney & Partners II, LLC 2/10/2017
** Signature of Reporting Person Date

/s/ James E. Thomas 2/10/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.